RADIANT-CERSI Innovator Support programme: MedForce AI unlocking new opportunities for business development through enhanced regulatory knowledge 

RADIANT-CERSI Innovator Support programme: MedForce AI unlocking new opportunities for business development through enhanced regulatory knowledge 

MedForceAI creates specialist diagnostic generative artificial intelligence (GenAI) products, which are designed to reduce waiting lists and prevent adverse events. Jay Liu, Co-founder and CEO at MedForceAI, enrolled on the RADIANT-CERSI Innovator Support programme with the ambition of strengthening his regulatory knowledge for AI as a medical device (AIaMD), as well as developing a clear regulatory roadmap, including timelines…

Continue Reading
A Culturally and Linguistically Tailored Intervention to Improve Diabetes-Related Outcomes in Chinese Americans With Type 2 Diabetes: Pilot Randomized Controlled Trial

A Culturally and Linguistically Tailored Intervention to Improve Diabetes-Related Outcomes in Chinese Americans With Type 2 Diabetes: Pilot Randomized Controlled Trial

Background: Chinese Americans with type 2 diabetes (T2D) face many linguistic, cultural, and social determinants of health–related barriers to accessing evidence-based diabetes interventions. Our team developed the culturally and linguistically tailored Chinese American Research…

Continue Reading